Literature DB >> 29124494

Information and support needs of young women regarding breast cancer risk and genetic testing: adapting effective interventions for a novel population.

Suzanne C O'Neill1, Chalanda Evans2, Rebekah J Hamilton3, Beth N Peshkin2, Claudine Isaacs4, Sue Friedman5, Kenneth P Tercyak2.   

Abstract

Young women from hereditary breast and ovarian cancer (HBOC) families face a unique set of challenges in managing their HBOC risk, where obtaining essential information to inform decision making is key. Previous work suggests that this need for specific health information also comes at a time of heightened distress and greater individuation from family. In this report, we describe our adaptation of a previously-studied behavioral intervention for this population, utilizing a systematic approach outlined by the Centers for Disease Control and Prevention. First, we assessed the information needs and levels of distress in this population and correlates of this distress. These data then were used to inform the adaptation and piloting of a three-session telephone-based peer coaching intervention. One hundred young women (M age = 25 years) who were first or second degree relatives of BRCA1/2 mutation carriers participated. Sixty-three percent of the sample endorsed unmet HBOC information needs and they, on average, reported moderate levels of cancer-related distress (M = 21.9, SD = 14.6). Greater familial disruption was associated with greater cancer-related distress in multivariable models (p < .05). Ten women who participated in the survey completed the intervention pilot. They reported lower distress from pre- to post- (15.8 vs. 12.0), as well as significantly lower decisional conflict (p < .05) and greater endorsement of an array of healthy coping strategies (i.e., active coping, instrumental coping, positive reframing, planning, p's < .05). Our survey results suggest that young adult women from HBOC families have unmet cancer genetic information and support needs. Our pilot intervention was able to reduce levels of decisional conflict and promote the use of effective coping strategies. This approach needs to be further tested in a larger randomized trial.

Entities:  

Keywords:  BRCA; Breast; Intervention; Peer; Telephone; Women

Mesh:

Year:  2018        PMID: 29124494      PMCID: PMC8156484          DOI: 10.1007/s10689-017-0059-x

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  37 in total

1.  BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.

Authors:  Shoshana M Rosenberg; Kathryn J Ruddy; Rulla M Tamimi; Shari Gelber; Lidia Schapira; Steven Come; Virginia F Borges; Bryce Larsen; Judy E Garber; Ann H Partridge
Journal:  JAMA Oncol       Date:  2016-06-01       Impact factor: 31.777

2.  Civilian PTSD scales: relationships with trait characteristics and everyday distress.

Authors:  Alicia C Shapinsky; Lisa J Rapport; Melinda J Henderson; Bradley N Axelrod
Journal:  Assessment       Date:  2005-06

Review 3.  Peer support in health care and prevention: cultural, organizational, and dissemination issues.

Authors:  Edwin B Fisher; Muchieh Maggy Coufal; Humberto Parada; Jennifer B Robinette; Patrick Y Tang; Diana M Urlaub; Claudia Castillo; Laura M Guzman-Corrales; Sayaka Hino; Jaimie Hunter; Ariana W Katz; Yael R Symes; Heidi P Worley; Cuirong Xu
Journal:  Annu Rev Public Health       Date:  2014-01-02       Impact factor: 21.981

4.  Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2.

Authors:  S M Domchek; M M Gaudet; J E Stopfer; M H Fleischaut; J Powers; N Kauff; K Offit; K L Nathanson; M Robson
Journal:  Breast Cancer Res Treat       Date:  2010-01       Impact factor: 4.872

5.  It's Interpersonal: Family Relationships, Genetic Risk, and Caregiving.

Authors:  Laura M Koehly
Journal:  Gerontologist       Date:  2016-08-09

6.  Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?

Authors:  Shiri Bernholtz; Yael Laitman; Bella Kaufman; Shnai Shimon-Paluch; Eitan Friedman
Journal:  Breast Cancer Res Treat       Date:  2011-11-24       Impact factor: 4.872

7.  Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.

Authors:  Marc D Schwartz; Heiddis B Valdimarsdottir; Tiffani A DeMarco; Beth N Peshkin; William Lawrence; Jessica Rispoli; Karen Brown; Claudine Isaacs; Suzanne O'Neill; Rebecca Shelby; Sherry C Grumet; Margaret M McGovern; Sarah Garnett; Heather Bremer; Suzanne Leaman; Kathryn O'Mara; Sarah Kelleher; Kathryn Komaridis
Journal:  Health Psychol       Date:  2009-01       Impact factor: 4.267

8.  Learning of your parent's BRCA mutation during adolescence or early adulthood: a study of offspring experiences.

Authors:  Angela R Bradbury; Linda Patrick-Miller; Kimberly Pawlowski; Comfort N Ibe; Shelly A Cummings; Fay Hlubocky; Olufunmilayo I Olopade; Christopher K Daugherty
Journal:  Psychooncology       Date:  2009-02       Impact factor: 3.894

9.  Measures of perceived social support from friends and from family: three validation studies.

Authors:  M E Procidano; K Heller
Journal:  Am J Community Psychol       Date:  1983-02

10.  Understanding the Needs of Young Women Regarding Breast Cancer Risk Assessment and Genetic Testing: Convergence and Divergence among Patient-Counselor Perceptions and the Promise of Peer Support.

Authors:  Chalanda Evans; Rebekah J Hamilton; Kenneth P Tercyak; Beth N Peshkin; Kantoniony Rabemananjara; Claudine Isaacs; Suzanne C O'Neill
Journal:  Healthcare (Basel)       Date:  2016-06-28
View more
  5 in total

1.  Evaluation of two mobile health apps for patients with breast cancer using the Mobile Application Rating Scale.

Authors:  Alexander Wright
Journal:  Mhealth       Date:  2021-10-20

2.  Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study.

Authors:  Anne Brédart; Jean-Luc Kop; Julia Dick; Alejandra Cano; Antoine De Pauw; Amélie Anota; Joan Brunet; Peter Devilee; Dominique Stoppa-Lyonnet; Rita Schmutzler; Sylvie Dolbeault
Journal:  BMJ Open       Date:  2019-09-24       Impact factor: 2.692

Review 3.  Helping Patients Understand and Cope with BRCA Mutations.

Authors:  Sukh Makhnoon; Banu Arun; Isabelle Bedrosian
Journal:  Curr Oncol Rep       Date:  2022-03-18       Impact factor: 5.945

4.  Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication.

Authors:  Samantha Pollard; Steve Kalloger; Deirdre Weymann; Sophie Sun; Jennifer Nuk; Kasmintan A Schrader; Dean A Regier
Journal:  Health Expect       Date:  2020-04-27       Impact factor: 3.377

Review 5.  Psychosocial Interventions for Women with a BRCA1 or BRCA2 Mutation: A Scoping Review.

Authors:  Talin Boghosian; Jeanna M McCuaig; Lindsay Carlsson; Kelly A Metcalfe
Journal:  Cancers (Basel)       Date:  2021-03-24       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.